Trends in nonoperative management of papillary thyroid microcarcinoma
- 18 March 2020
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 121 (6) , 952-957
Abstract
Background: In 2010, a Japanese trial of nonoperative management for papillary thyroid microcarcinomas (PTmC) was published. This study determines if the prevalence of nonoperative management in the United States has changed and if there are predictors of this approach.Methods: Patients treated for PTmC between 2004 and 2015 in the National Cancer Data Base were identified. Inclusion criteria were: classic or follicular variant papillary cancer histology, tumor size 1 to 10 mm, cN0 disease and no extrathyroidal extension or metastatic disease. Nonoperative management was assessed over time and compared between 2004‐2010 and 2010‐2015. Logistic regression identified factors associated with nonoperative management.Results: Of 65 381 PTmC patients, 344 (0.5%) were treated nonoperatively. The annual rate of nonoperative management was similar at 0.6% in 2004 to 0.4% in 2010 (P = .755) but increased to 0.9% in 2015 (P < .001). There was no difference in patient age, race, comorbidities, or reason for nonoperative management between the two periods. Academic centers managed more patients nonoperatively. Multivariable logistic regression suggests older age, facility type, location, Hispanic, Asian, and Native American ethnicity were associated with nonoperative management.Conclusion: The vast majority of PTmC in the United States is treated with an operation. A small but significant increase in nonoperative management occurred between 2004‐2010 and 2010‐2015.Keywords
This publication has 17 references indexed in Scilit:
- Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the ThyroidWorld Journal of Surgery, 2016
- 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2016
- A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary MicrocarcinomaThyroid®, 2016
- The Impact of Diagnostic Changes on the Rise in Thyroid Cancer Incidence: A Population-Based Study in Selected High-Resource CountriesThyroid®, 2015
- American Association of Clinical Endocrinologists and American College of Endocrinology Disease State Clinical Review: The Increasing Incidence of Thyroid CancerEndocrine Practice, 2015
- Nonoperative management of low-risk differentiated thyroid carcinomaCurrent Opinion in Oncology, 2015
- Korea's Thyroid-Cancer “Epidemic” — Screening and OverdiagnosisNew England Journal of Medicine, 2014
- Patients with follicular and Hurthle cell microcarcinomas have compromised survival: A population level study of 22,738 patientsSurgery, 2013
- Three Distinctly Different Kinds of Papillary Thyroid Microcarcinoma should be Recognized: Our Treatment Strategies and OutcomesWorld Journal of Surgery, 2010
- Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005Cancer, 2009